Association of in-hospital use of cardiovascular therapies with the risk of in-hospital death in patients with COVID-19 with prehospital exposure to the treatment of interest.</p
History of cardiovascular diseases (CVDs) may influence the prognosis of patients hospitalised for C...
The presence of any underlying heart condition could influence outcomes during the coronavirus disea...
Odds ratios with 95% confidence intervals for in-hospital death for prehospital use (vs. no prehospi...
Association of prehospital cardiovascular therapy exposure with the risk of in-hospital death in pat...
Association of initiation of cardiovascular therapies with the risk of in-hospital death in patients...
Association of discontinuation of cardiovascular therapies with the risk of in-hospital death in pat...
To assess the associations of exposure and modifications in exposure (i.e., discontinuation on admis...
Background: The coronavirus disease 19 (COVID-19) recently became one of the leading causes of death...
Contrasting data have been published about the impact of cardiovascular disease on Covid-19. A compr...
Introduction The coronavirus disease 2019 (COVID-19) pandemic is the largest public health challeng...
Patients with cardiac disease are considered high risk for poor outcomes following hospitalization w...
Aims Patients with cardiac disease are considered high risk for poor outcomes following hospitalizat...
AimsPatients with cardiac disease are considered high risk for poor outcomes following hospitalizati...
While pre-existing cardiovascular disease (CVD) appears to be associated with poor outcomes in patie...
The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has profoundly imp...
History of cardiovascular diseases (CVDs) may influence the prognosis of patients hospitalised for C...
The presence of any underlying heart condition could influence outcomes during the coronavirus disea...
Odds ratios with 95% confidence intervals for in-hospital death for prehospital use (vs. no prehospi...
Association of prehospital cardiovascular therapy exposure with the risk of in-hospital death in pat...
Association of initiation of cardiovascular therapies with the risk of in-hospital death in patients...
Association of discontinuation of cardiovascular therapies with the risk of in-hospital death in pat...
To assess the associations of exposure and modifications in exposure (i.e., discontinuation on admis...
Background: The coronavirus disease 19 (COVID-19) recently became one of the leading causes of death...
Contrasting data have been published about the impact of cardiovascular disease on Covid-19. A compr...
Introduction The coronavirus disease 2019 (COVID-19) pandemic is the largest public health challeng...
Patients with cardiac disease are considered high risk for poor outcomes following hospitalization w...
Aims Patients with cardiac disease are considered high risk for poor outcomes following hospitalizat...
AimsPatients with cardiac disease are considered high risk for poor outcomes following hospitalizati...
While pre-existing cardiovascular disease (CVD) appears to be associated with poor outcomes in patie...
The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has profoundly imp...
History of cardiovascular diseases (CVDs) may influence the prognosis of patients hospitalised for C...
The presence of any underlying heart condition could influence outcomes during the coronavirus disea...
Odds ratios with 95% confidence intervals for in-hospital death for prehospital use (vs. no prehospi...